Octave Specialty (OSG) Cash & Equivalents (2010 - 2026)

Octave Specialty's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $93.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 81.06% year-over-year to $93.5 million; the TTM figure through Mar 2026 stood at $93.5 million (up 81.06% YoY), while the FY2025 annual figure was $68.4 million, up 44.77% from the prior year.
• Cash & Equivalents was $93.5 million for Q1 2026 at Octave Specialty, up from $68.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $309.0 million in Q2 2023 to a low of $19.2 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $94.9 million across 5 years, with a median of $51.7 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 694.74% in 2023, then plunged 91.88% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $19.9 million in 2022, then dropped by 3.6% to $19.2 million in 2023, then jumped by 145.93% to $47.3 million in 2024, then jumped by 44.77% to $68.4 million in 2025, then soared by 36.67% to $93.5 million in 2026.
• The last three Cash & Equivalents figures came in at $93.5 million (Q1 2026), $68.4 million (Q4 2025), and $51.8 million (Q3 2025), per Business Quant data.